A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)

被引:0
|
作者
Grivas, P. [1 ]
Sridhar, S. [2 ]
Perez Valderrama, B. [3 ]
Castellano Gauna, D. E. [4 ]
Loriot, Y. [5 ]
Doger de Speville, B. [6 ]
Pouessel, D. [7 ]
van der Heijden, M. S. [8 ]
Galsky, M. D. [9 ]
Gulati, S. [10 ]
Ravaud, A. [11 ]
Fontana, E. [12 ]
Spira, A. I. [13 ]
Gartrell, B. A. [14 ]
Mortazavi, A. [15 ]
Isambert, N. [16 ]
Baxter, D. [17 ]
Powles, T. B. [18 ]
Khaled, A. H. [19 ]
Morales Barrera, R. [20 ]
机构
[1] Univ Washington, Dept Med Oncol, Seattle Canc Care Alliance, Seattle, WA USA
[2] UHN, Dept Med Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Hosp Univ Virgen del Rocio, Dept Med Oncol, Seville, Spain
[4] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[5] Inst Gustave Roussy, Dept Canc Med, Villejuif, France
[6] Univ Hosp Fdn Jimenez Diaz, Start Madrid Phase 1 Unit, Madrid, Spain
[7] Icr Iuct Oncopole, Dept Med Oncol, Toulouse, France
[8] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[9] Icahn Sch Med, Tisch Canc Inst, Mt Sinai Hosp, New York, NY USA
[10] UC Davis Comprehens Canc Ctr, Hematol & Oncol Dept, Sacramento, CA USA
[11] CHU Bordeaux Hop St Andre, Dept Med Oncol, Bordeaux, France
[12] Sarah Cannon Res Inst SCRI UK, Drug Dev, London, England
[13] Virginia Canc Specialist, Res Inst, Fairfax, VA USA
[14] Montefiore Einstein Ctr Canc Care, Oncol & Urol, Bronx, NY USA
[15] Ohio State Univ, Med Oncol Dept, Wexner Med Ctr, Columbus, OH USA
[16] CHU Poitiers, Dept Med Oncol, Jean Bernard Hop, Poitiers, France
[17] GSK USA, Collegeville, PA USA
[18] St Bartholomews Hosp Barts Hlth NHS Trust, Dept Oncol, London, England
[19] GSK USA, Dept Oncol, Collegeville, PA USA
[20] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain
关键词
D O I
10.1016/j.annonc.2023.09.1023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2374P
引用
收藏
页码:S1209 / S1210
页数:2
相关论文
共 50 条
  • [21] Phase II trial of eribulin mesylate as a first- or second-line treatment for locally advanced or metastatic breast cancer: a multicenter, single-arm trial
    Tetsu Hayashida
    Hiromitsu Jinno
    Katsuaki Mori
    Hiroki Sato
    Akira Matsui
    Takashi Sakurai
    Hiroaki Hattori
    Shin Takayama
    Masahiro Wada
    Maiko Takahashi
    Hirohito Seki
    Tomoko Seki
    Aiko Nagayama
    Akiko Matsumoto
    Yuko Kitagawa
    BMC Cancer, 18
  • [22] CapOX as neoadjuvant chemotherapy for locally advanced operable colon cancer patients: a prospective single-arm phase II trial
    Liu, Fangqi
    Yang, Li
    Wu, Yuchen
    Li, Cong
    Zhao, Jiang
    Keranmu, Adili
    Zheng, Hongtu
    Huang, Dan
    Wang, Lei
    Tong, Tong
    Xu, Junyan
    Zhu, Ji
    Cai, Sanjun
    Xu, Ye
    CHINESE JOURNAL OF CANCER RESEARCH, 2016, 28 (06) : 589 - 597
  • [23] The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-Arm Phase II Clinical Trial
    Huang, Nai-si
    Wei, Wen-jun
    Xiang, Jun
    Chen, Jia-ying
    Guan, Qing
    Lu, Zhong-wu
    Ma, Ben
    Sun, Guo-hua
    Wang, Yu-long
    Ji, Qing-hai
    Wang, Yu
    THYROID, 2021, 31 (12) : 1808 - 1813
  • [24] Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
    Colombo, N.
    McMeekin, D. S.
    Schwartz, P. E.
    Sessa, C.
    Gehrig, P. A.
    Holloway, R.
    Braly, P.
    Matei, D.
    Morosky, A.
    Dodion, P. F.
    Einstein, M. H.
    Haluska, F.
    BRITISH JOURNAL OF CANCER, 2013, 108 (05) : 1021 - 1026
  • [25] Ridaforolimus as a single agent in advanced endometrial cancer: results of a single-arm, phase 2 trial
    N Colombo
    D S McMeekin
    P E Schwartz
    C Sessa
    P A Gehrig
    R Holloway
    P Braly
    D Matei
    A Morosky
    P F Dodion
    M H Einstein
    F Haluska
    British Journal of Cancer, 2013, 108 : 1021 - 1026
  • [26] A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma
    Marsh, Robert de W.
    Lima, C. M. Rocha
    Levy, D. E.
    Mitchell, E. P.
    Rowland, K. M., Jr.
    Benson, A. B., III
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (01): : 26 - 31
  • [27] Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial
    Martin-Broto, Javier
    Hindi, Nadia
    Grignani, Giovanni
    Martinez-Trufero, Javier
    Redondo, Andres
    Valverde, Claudia
    Stacchiotti, Silvia
    Lopez-Pousa, Antonio
    D'Ambrosio, Lorenzo
    Gutierrez, Antonio
    Perez-Vega, Herminia
    Encinas-Tobajas, Victor
    de Alava, Enrique
    Collini, Paola
    Pena-Chilet, Maria
    Dopazo, Joaquin
    Carrasco-Garcia, Irene
    Lopez-Alvarez, Maria
    Moura, David S.
    Lopez-Martin, Jose A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [28] Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
    Rosenberg, Jonathan E.
    Hoffman-Censits, Jean
    Powles, Tom
    van der Heijden, Michiel S.
    Balar, Arjun V.
    Necchi, Andrea
    Dawson, Nancy
    O'Donnell, Peter H.
    Balmanoukian, Ani
    Loriot, Yohann
    Srinivas, Sandy
    Retz, Margitta M.
    Grivas, Petros
    Joseph, Richard W.
    Galsky, Matthew D.
    Fleming, Mark T.
    Petrylak, Daniel P.
    Perez-Gracia, Jose Luis
    Burris, Howard A.
    Castellano, Daniel
    Canil, Christina
    Bellmunt, Joaquim
    Bajorin, Dean
    Nickles, Dorothee
    Bourgon, Richard
    Frampton, Garrett M.
    Cui, Na
    Mariathasan, Sanjeev
    Abidoye, Oyewale
    Fine, Gregg D.
    Dreicer, Robert
    LANCET, 2016, 387 (10031): : 1909 - 1920
  • [29] Phase 1 trial of first-line bintrafusp alfa in combination with other anticancer therapies in patients (pts) with locally advanced or advanced cervical cancer.
    Oaknin, Ana
    Ghamande, Sharad A.
    Kasamatsu, Yuka
    Gil-Martin, Marta
    Diver, Elisabeth J.
    Jehl, Genevieve
    Gleicher, Stephan A.
    Chaudhary, Surendra
    Vugmeyster, Yulia
    Hasegawa, Kosei
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Phase 1b trial of cirmtuzumab and paclitaxel for locally advanced, unresectable and metastatic breast cancer
    Shatsky, Rebecca A.
    Schwab, Richard B.
    Helsten, Teresa L.
    Pittman, Emily I.
    Chen, Ruifeng
    Breitmeyer, James B.
    Jamieson, Catriona H. M.
    Kipps, Thomas J.
    Parker, Barbara A.
    CANCER RESEARCH, 2020, 80 (04)